Alex Levit's most recent trade in Context Therapeutics Inc was a trade of 349,900 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 13, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Context Therapeutics Inc | Alex Levit | Chief Legal Officer, Corp. Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 349,900 | 349,900 | - | - | Stock Option (right to buy) | |
Context Therapeutics Inc | Alex Levit | Chief Legal Officer, Corp. Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2024 | 153,515 | 153,515 | - | - | Stock Option (right to buy) | |
Context Therapeutics Inc | Alex Levit | Chief Legal Officer, Corp. Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 151,505 | 151,505 | - | - | Stock Option (right to buy) | |
Context Therapeutics Inc | Alex Levit | Chief Legal Officer, Corp. Sec | Purchase of securities on an exchange or from another person at price $ 0.85 per share. | 09 Dec 2022 | 6,000 | 9,000 | - | 0.8 | 5,095 | Common Stock |
Context Therapeutics Inc | Alex Levit | Chief Legal Officer, Corp. Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 107,870 | 107,870 | - | - | Stock Option (right to buy) | |
Context Therapeutics Inc | Alex Levit | Chief Legal Officer, Corp. Sec | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 22 Oct 2021 | 3,000 | 3,000 | - | 5 | 15,000 | Common Stock |